THE METABOLIC SYNDROME AS AN ENDOCRINE DISEASE: ¿IS THERE AN EFFECTIVE PHARMACOTHERAPEUTIC STRATEGY OPTIMALLY TARGETING THE PATHOGENESIS?

Para ver esta información, visualizar aquí